Since 29.04.2023, new Russian Patent Requirements (the Requirements) have been in force. These include several amendments compared to the previous version of the requirements, including an amended…
A recent decision issued by the federal district court could impact medical use patents in Brazil. In an invalidity lawsuit filed by the Brazilian affiliate of Sun Pharma against Boehringer Ingelheim…
Introduction
On 17 July 2023, the English Court of Appeal handed down its decision in a dispute between J.C. Bamford (JCB) and Manitou about the confidentiality of information disclosed in the…
My British colleague has already commented brilliantly on the UK ruling in this case from the point of view of plausibility (see here). For my part, I'd like to comment the French ruling in the same…
On 18 July 2023, the Court of Appeal handed down its judgment in Vernacare Limited v Moulded Fibre Products Limited [2023] EWCA Civ 841, an appeal from the decision of Nicholas Caddick QC (sitting as…
In decision T 438/19 Technical Board of Appeal 3.3.03 has ex officio (!) referred three questions of law to the Enlarged Board of Appeal (now handled as G 1/23) in order to resolve a perceived…
To ensure you don’t miss out on interesting IP law developments reported on our other IP blogs, we will, on a regular basis, provide you with an overview of the most-read posts from each of our IP…
“One person's happiness is another person’s misfortune” (i.e., “le bonheur des uns fait le malheur des autres”)... This French proverb could easily be applied to the subject I'm dealing with today:…
The combination of two well-known high blood pressure medicines did not result in unexpected patient benefits.
The U.S. Court of Appeals for the Federal Circuit has upheld a decision by the Patent…
June 2023 has just passed, and the newly minted Unified Patent Court is of course still on everyone's lips. But, of course, there are many reasons why the novel court system might not be the perfect…
